Therapeutic Effects of Curcumin against Bladder Cancer: A Review of Possible Molecular Pathways
- PMID: 32013836
- DOI: 10.2174/1871520620666200203143803
Therapeutic Effects of Curcumin against Bladder Cancer: A Review of Possible Molecular Pathways
Abstract
There are concerns about the increased incidence of cancer both in developing and developed countries. In spite of recent progress in cancer therapy, this disease is still one of the leading causes of death worldwide. Consequently, there have been rigorous attempts to improve cancer therapy by looking at nature as a rich source of naturally occurring anti-tumor drugs. Curcumin is a well-known plant-derived polyphenol found in turmeric. This compound has numerous pharmacological effects such as antioxidant, anti-inflammatory, antidiabetic and anti-tumor properties. Curcumin is capable of suppressing the growth of a variety of cancer cells including those of bladder cancer. Given the involvement of various signaling pathways such as PI3K, Akt, mTOR and VEGF in the progression and malignancy of bladder cancer, and considering the potential of curcumin in targeting signaling pathways, it seems that curcumin can be considered as a promising candidate in bladder cancer therapy. In the present review, we describe the molecular signaling pathways through which curcumin inhibits invasion and metastasis of bladder cancer cells.
Keywords: Curcumin; bladder cancer; cancer therapy; herbal medicine; polyphenol; signaling pathway..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Highly stable selenadiazole derivatives induce bladder cancer cell apoptosis and inhibit cell migration and invasion through the activation of ROS-mediated signaling pathways.Dalton Trans. 2016 Nov 22;45(46):18465-18475. doi: 10.1039/c6dt02045c. Dalton Trans. 2016. PMID: 27711726
-
Curcumin downregulates the PI3K-AKT-mTOR pathway and inhibits growth and progression in head and neck cancer cells.Phytother Res. 2020 Dec;34(12):3311-3324. doi: 10.1002/ptr.6780. Epub 2020 Jul 6. Phytother Res. 2020. PMID: 32628350
-
Molecular targets of curcumin for cancer therapy: an updated review.Tumour Biol. 2016 Oct;37(10):13017-13028. doi: 10.1007/s13277-016-5183-y. Epub 2016 Jul 28. Tumour Biol. 2016. PMID: 27468716 Review.
-
Therapeutic Applications of Curcumin and its Novel Formulations in the Treatment of Bladder Cancer: A Review of Current Evidence.Anticancer Agents Med Chem. 2021;21(5):587-596. doi: 10.2174/1871520620666200807223832. Anticancer Agents Med Chem. 2021. PMID: 32767956 Review.
-
Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs.Int J Biol Sci. 2019 May 7;15(6):1200-1214. doi: 10.7150/ijbs.33710. eCollection 2019. Int J Biol Sci. 2019. PMID: 31223280 Free PMC article. Review.
Cited by
-
Comparation of Anti-Inflammatory and Antioxidantactivities of Curcumin, Tetrahydrocurcuminand Octahydrocurcuminin LPS-Stimulated RAW264.7 Macrophages.Evid Based Complement Alternat Med. 2020 Dec 22;2020:8856135. doi: 10.1155/2020/8856135. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 33424997 Free PMC article.
-
KLF16 Downregulates the Expression of Tumor Suppressor Gene TGFBR3 to Promote Bladder Cancer Proliferation and Migration.Cancer Manag Res. 2022 Feb 9;14:465-477. doi: 10.2147/CMAR.S334521. eCollection 2022. Cancer Manag Res. 2022. PMID: 35173481 Free PMC article.
-
Chitosan-based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy.Bioeng Transl Med. 2022 Sep 13;8(1):e10325. doi: 10.1002/btm2.10325. eCollection 2023 Jan. Bioeng Transl Med. 2022. PMID: 36684100 Free PMC article. Review.
-
Drug screening and biomarker gene investigation in cancer therapy through the human transcriptional regulatory network.Comput Struct Biotechnol J. 2023 Feb 8;21:1557-1572. doi: 10.1016/j.csbj.2023.02.005. eCollection 2023. Comput Struct Biotechnol J. 2023. PMID: 36879883 Free PMC article.
-
Sinomenine Inhibits the Progression of Bladder Cancer Cells by Downregulating LncRNA-HEIH Expression.Evid Based Complement Alternat Med. 2021 Nov 1;2021:4699529. doi: 10.1155/2021/4699529. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34760016 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous